| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.MIB.0000160742.91602.B7 |
| P698 | PubMed publication ID | 15973124 |
| P2093 | author name string | Gary R Lichtenstein | |
| Faten N Aberra | |||
| P2860 | cites work | A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators | Q28145430 |
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome | Q45116890 | ||
| Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene | Q45163785 | ||
| High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy | Q47808177 | ||
| The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study | Q47885840 | ||
| Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. | Q50571317 | ||
| Effect of systemic steroids on ileal pouch-anal anastomosis in patients with ulcerative colitis. | Q50611395 | ||
| A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. | Q51344291 | ||
| Effect of age on susceptibility to post-traumatic infection in the elderly. | Q51680843 | ||
| The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. | Q53854379 | ||
| A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. | Q54344506 | ||
| Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. | Q55266577 | ||
| Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man | Q57265461 | ||
| Methotrexate for the Treatment of Crohn's Disease | Q59120846 | ||
| Low-Dose Cyclosporine for the Treatment of Crohn's Disease | Q59120870 | ||
| Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial | Q28202504 | ||
| Infliximab maintenance therapy for fistulizing Crohn's disease | Q28246982 | ||
| Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group | Q28247663 | ||
| Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial | Q28281664 | ||
| Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery | Q28348438 | ||
| Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate | Q28378283 | ||
| Cytomegaloviral enterocolitis: clinical associations and outcome | Q33598634 | ||
| Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
| Diagnosis and prognostic markers of HCMV infection | Q34277019 | ||
| A controlled double blind study of azathioprine in the management of Crohn's disease | Q34408881 | ||
| Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study | Q34409966 | ||
| Pharmacokinetic considerations in the treatment of inflammatory bowel disease | Q34437920 | ||
| The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients | Q34544307 | ||
| Clinical practice. Herpes zoster | Q34768980 | ||
| Perioperative management of patients treated with glucocorticoids | Q35151395 | ||
| Molecular mechanism of methotrexate action in inflammation | Q35501813 | ||
| Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature | Q35745108 | ||
| Randomised controlled trial of azathioprine withdrawal in ulcerative colitis | Q35822294 | ||
| Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone | Q36466503 | ||
| Incidence of serious complications of corticosteroid therapy in respiratory disease: A retrospective survey of patients in the Brompton Hospital | Q36478948 | ||
| Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease | Q39515939 | ||
| A double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis | Q40314397 | ||
| Urinary complications of Crohn's disease | Q40363125 | ||
| Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease | Q40524189 | ||
| Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine | Q40688732 | ||
| Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine | Q40695651 | ||
| Liver abscess as the initial manifestation of colonic Crohn's disease: Report of a case | Q40749264 | ||
| Cyclosporin clinical pharmacokinetics | Q40918376 | ||
| Molecular therapeutics. Methotrexate and its mechanism of action | Q41266413 | ||
| Tuberculosis in heart transplant recipients | Q41355145 | ||
| Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease | Q41880670 | ||
| Clostridium difficile and inflammatory bowel disease | Q41959912 | ||
| Genital condylomata in a patient receiving infliximab for Crohn's disease | Q43063870 | ||
| Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis | Q43582796 | ||
| Outcome of cytomegalovirus infections in patients with inflammatory bowel disease | Q43684194 | ||
| Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications | Q43764915 | ||
| Bacterial translocation in patients with Crohn's disease undergoing surgery | Q43797088 | ||
| Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis | Q43798421 | ||
| Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients | Q43842151 | ||
| Cytomegalovirus infection associated with onset of inflammatory bowel disease | Q44129468 | ||
| Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients | Q44532951 | ||
| Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease | Q44797413 | ||
| Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study | Q44855780 | ||
| Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy | Q44884726 | ||
| Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. | Q45054685 | ||
| P433 | issue | 7 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 685-695 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Methods to avoid infections in patients with inflammatory bowel disease | |
| P478 | volume | 11 |
| Q34073191 | Adverse events in IBD: to stop or continue immune suppressant and biologic treatment |
| Q41489713 | Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial |
| Q45007560 | Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors |
| Q38108468 | Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy |
| Q37564012 | Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease |
| Q38227191 | Gender-related differences in clinical course of crohn?s disease in an Asian population: a retrospective cohort review |
| Q37466464 | Immunizations in patients with inflammatory bowel disease |
| Q33564492 | Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis |
| Q34274824 | Influenza vaccination coverage in children with inflammatory bowel disease |
| Q38232338 | Long-term safety of immunomodulators in pediatric inflammatory diseases |
| Q34173362 | Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines |
| Q37327937 | Preventative care for patients with inflammatory bowel disease in the Veterans Health Administration. |
| Q34008766 | Preventing infective complications in inflammatory bowel disease |
| Q36971789 | Prevention of infection caused by immunosuppressive drugs in gastroenterology. |
| Q36521192 | Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease |
| Q42106968 | Refractory ulcerative colitis treatment |
| Q47684194 | Risk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study |
| Q38092279 | Spontaneous abdominopelvic abscess as an initial manifestation of Crohn's disease: a retrospective cohort review |
| Q40327479 | The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines |
| Q38351215 | Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009. |
| Q47555158 | Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease |
Search more.